Abstract:Background: B-cell lymphoma 6 (BCL6) is a transcription repressor that plays a tumor suppressor or promoting role in various tumors. However, its function and molecular mechanism in gastric cancer (GC) remain unclear. Ferroptosis, a novel programmed cell death, is closely related to tumor development. In this research, we aimed to explore the role and mechanism of BCL6 in malignant progression and ferroptosis of gastric cancer. Methods: Firstly, BCL6 was identified as an important biomarker that attenuated the proliferation and metastasis of GC through tumor microarrays and confirmed in GC cell lines. RNA sequence was performed to explore the downstream genes of BCL6. The underlying mechanisms were further investigated by ChIP, dual luciferase reporter assays and rescue experiments. Cell death, lipid peroxidation, MDA and Fe2+ level were detected to determine the effect of BCL6 on ferroptosis and the mechanism was revealed. CHX, MG132 treatment and rescue experiments were used to explore the upstream regulatory mechanism of BCL6. Results: Here we showed that BCL6 expression was significantly decreased in GC tissues, and patients with low BCL6 expression showed more malignant clinical features and poor prognosis. The upregulation of BCL6 may significantly inhibited the proliferation and metastasis of GC cells in vitro and in vivo. In addition, we found that BCL6 directly binds and transcriptionally represses Wnt receptor Frizzled 7 (FZD7) to inhibit the proliferation, metastasis of GC cells. We also found that BCL6 promoted lipid peroxidation, MDA and Fe2+ level to facilitate ferroptosis of GC cells by FZD7/β-catenin/TP63/GPX4 pathway. Furthermore, the expression and function of BCL6 in GC were regulated by the ring finger protein 180 (RNF180)/ras homolog gene family member C (RhoC) pathway, which had been elucidated to be involved in significantly mediating the proliferation and metastasis of GC cells. Conclusions: In summary, BCL6 should be considered a potential intermediate tumor suppressor to inhibit the malignant progression and induce ferroptosis, which might be a promising molecular biomarker for further mechanistic investigation of GC.

Epigenetic Inactivation of Bcl6b, A Novel Functional Tumour Suppressor for Gastric Cancer, is Associated with Poor Survival

The Survival Decrease in Gastric Cancer is Associated with the Methylation of B-cell CLL/lymphoma 6 Member B Promoter

High BCL6 Expression Predicts Better Prognosis, Independent of BCL6 Translocation Status, Translocation Partner, or BCL6-deregulating Mutations, in Gastric Lymphoma.

Klotho is Silenced Through Promoter Hypermethylation in Gastric Cancer

Promoter Hypermethylation of BCL6B Gene is a Potential Plasma DNA Biomarker for Gastric Cancer.

Epigenetic Silencing BCL6B Induced Colorectal Cancer Proliferation and Metastasis by Inhibiting P53 Signaling.

Annexin A6 is down-regulated through promoter methylation in gastric cancer.

Eif4ebp3 Was Downregulated by Methylation and Acted As a Tumor Suppressor by Targeting Eif4e/β-Catenin in Gastric Cancer.

BCLB, Methylated in Hepatocellular Carcinoma, is a Starvation Stress Sensor That Induces Apoptosis and Autophagy Through the AMPK-mTOR Signaling Cascade

BCL6B Hypermethylation Predicts Metastasis and Poor Prognosis in Early-Stage Hepatocellular Carcinoma after Thermal Ablation

Prognostic Implications of MYBL2 in Resected Chinese Gastric Adenocarcinoma Patients

Transmembrane Protein 106A is Silenced by Promoter Region Hypermethylation and Suppresses Gastric Cancer Growth by Inducing Apoptosis.

Abstract 2950: Epigenetic Silencing BCL6B Inactivates P53 Signaling and Causes Human Hepatocellular Carcinoma Cell Resist to 5-FU

The malignancy suppression and ferroptosis facilitation of BCL6 in gastric cancer mediated by FZD7 repression are strengthened by RNF180/RhoC pathway

DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.

Bcl2l10 Protein Regulates Apoptosis/Proliferation Through Differential Pathways in Gastric Cancer Cells

Epigenetic Inactivation of BCL6B, a Functional Tumor Suppressor for Gastric Cancer, is Associated with Poor Survival of Gastric Cancer

Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.

Poor Survival is Associated with the Methylated Degree of Zinc-Finger Protein 545 (znf545) Dna Promoter in Gastric Cancer

Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer

B Cell CLL/lymphoma 6 Member B Inhibits Hepatocellular Carcinoma Metastases in Vitro and in Mice.